HK Stock MarketDetailed Quotes

02162 KEYMED BIO-B

Watchlist
  • 35.600
  • -0.600-1.66%
Closing Auction Session Sep 10 16:02 CST
9.96BMarket Cap-12233P/E (TTM)

KEYMED BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KEYMED BIO-B H1 FY2024 Earnings Date

Currency：CNYAug 27, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
54.68M
--
-83.28%
EPS
--
-1.31
--
-827.80%
Analyst Rating
Strong Buy

Sep 10, 2024

KEYMED BIO-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 531.269M--
--2024/FY-- / 129.242M--
Mar 26, 20242023/FY354.095M / 356.052M--
Mar 17, 20232022/FY100.063M / 128.000M--
Mar 29, 20222021/FY110.269M / 80.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 531.269M--
--2024/FY-- / 129.242M--
Mar 26, 20242023/FY354.095M / 356.052M--
Mar 17, 20232022/FY100.063M / 128.000M--
Mar 29, 20222021/FY110.269M / 80.000M--

Unlock Free Earnings Estimates

KEYMED BIO-B Earnings Reports

  • KEYMED BIO-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024

    Aug 27 06:23 ET

  • KEYMED BIO-B: DATE OF BOARD MEETING

    Aug 15 04:35 ET

  • KEYMED BIO-B: 2023 ANNUAL REPORT

    Apr 24 04:30 ET

  • KEYMED BIO-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2023AND PROPOSED AMENDMENTS TO THE MEMORANDUM ANDARTICLES OF ASSOCIATION OF THE COMPANY

    Mar 26 09:39 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 10, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    % Chg